ATTR-CM care pathway collaboration with Viz.ai

Alnylam said it is partnering with Viz.ai to develop an AI-enabled ATTR-CM care pathway that combines an FDA-cleared Us2.ai echocardiography algorithm with electronic health record connectivity. The release says the related AWARE study will launch at five pilot health systems later in 2026 to generate real-world evidence.